Kato, Chris
Morimoto, Satoru
Takahashi, Shinichi
Daté, Yugaku
Okada, Kensuke
Okano, Hideyuki
Nakahara, Jin
Ito, Daisuke http://orcid.org/0000-0002-4740-1675
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology of Japan (21H02812)
Foundation of Japan Amyotrophic Lateral Sclerosis Association, Ice Bucket Challenge Grant
Serika Fund
Buoniconti Fund to Cure Paralysis
Japan Agency for Medical Research and Development (JP 18ek0109395, JP 19ek0109395, JP 20ek0109395, JP 18ek0109329, JP 19ek0109329, JP 20ek0109329)
Article History
Received: 22 May 2021
Revised: 22 September 2021
Accepted: 15 October 2021
First Online: 25 October 2021
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest, except that HO is a founder scientist and a Scientific Advisory Board of SanBio Co. Ltd. and K Pharma Inc and DI is the principal investigator of the VALOR study [ClinicalTrials.gov Identifier: NCT02623699].
: The study design and protocol were approved by the Ethics Committee for Human Research of the Keio University School of Medicine (#20200287).